The Psychological Impact of Vitiligo in Saudi Arabia.
dlqi
heath related quality of life
kingdom of saudi arabia (ksa)
phq-9
vitiligo
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
19
08
2023
medline:
20
9
2023
pubmed:
20
9
2023
entrez:
20
9
2023
Statut:
epublish
Résumé
Background Vitiligo, the most common pigment disorder, impacts 0.5-2% of the global population, often causing psychological distress due to appearance changes and potential discrimination. Existing data on depressive symptoms and quality of life (QoL) effects in Saudi Arabian vitiligo patients are limited and inconsistent. Hence, this multi-center investigation was conducted in Saudi Arabia to determine the prevalence of depressive symptoms and quality of life (QoL) impairment in patients with vitiligo and to identify factors linked to increased psychological distress in this population. Methods We conducted a multi-center cross-sectional study in Saudi Arabia, employing two validated Arabic questionnaires, the Dermatology Life Quality Index (DLQI) and the Patient Health Questionnaire-9 items (PHQ-9), along with demographic information. Appropriate statistical analyses were performed. Results In total, 204 patients completed the survey. The median DLQI was 4 (range: 25), while the median PHQ-9 was 5 (range: 27). Factors associated with worse QoL included an early age of onset (under 18 years) and a disease duration exceeding five years. Conversely, only disease duration correlated with worse PHQ-9 scores. Vitiligo lesions on the lower extremities, feet, and genitalia were linked to poorer DLQI scores, while only genitalia were associated with worse PHQ-9 scores. We recommend further social awareness campaigns emphasizing the role of supportive families to improve the well-being of vitiligo patients.
Identifiants
pubmed: 37727157
doi: 10.7759/cureus.43767
pmc: PMC10506855
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e43767Informations de copyright
Copyright © 2023, Alkhowailed et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Sultan Qaboos Univ Med J. 2016 May;16(2):e217-23
pubmed: 27226914
Int J Dermatol. 2012 Oct;51(10):1206-12
pubmed: 22458952
Int J Gen Med. 2012;5:633-42
pubmed: 22866015
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
JAMA Dermatol. 2013 Feb;149(2):159-64
pubmed: 23560296
Am J Clin Dermatol. 2021 Nov;22(6):757-774
pubmed: 34554406
Am J Clin Dermatol. 2013 Dec;14(6):489-95
pubmed: 23839260
J Affect Disord. 2004 Feb;78(2):131-40
pubmed: 14706723
Br J Gen Pract. 2009 Sep;59(566):e283-8
pubmed: 19761655
Dermatol Clin. 2017 Apr;35(2):117-128
pubmed: 28317521
Dermatology. 2016;232(5):619-625
pubmed: 27603174
J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1343-1351
pubmed: 29222958
Mater Sociomed. 2020 Jun;32(2):108-111
pubmed: 32843857
Dermatology. 2020;236(6):571-592
pubmed: 32155629
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1507-1523
pubmed: 35366355
J Cosmet Dermatol. 2021 Jan;20(1):159-165
pubmed: 32406129
J Cutan Med Surg. 2015 Jan-Feb;19(1):50-6
pubmed: 25775664
Int J Womens Dermatol. 2018 Jan 08;4(1):32-37
pubmed: 29872674
Cogn Behav Ther. 2011;40(2):126-36
pubmed: 25155813
Saudi Med J. 2021 Jun;42(6):682-687
pubmed: 34078732
J Invest Dermatol. 2005 Oct;125(4):659-64
pubmed: 16185263
J Dermatol. 2011 May;38(5):419-31
pubmed: 21667529
Br J Gen Pract. 2008 Jan;58(546):32-6
pubmed: 18186994
J Affect Disord. 2013 Mar 5;145(3):341-3
pubmed: 23021192
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Cutan Med Surg. 2015 May-Jun;19(3):297-303
pubmed: 25775649
Saudi Med J. 2007 Sep;28(9):1414-7
pubmed: 17768471
Int J Dermatol. 2016 Jun;55(6):608-14
pubmed: 26749040